Skip to main content

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

New KCE report on the performance of the Belgian healthcare system

In June 2023, the Belgian Health Care Knowledge Center (KCE) published Health Services Research concerning the performance of the Belgian healthcare system. KCE regularly conducts such "check-ups" of the healthcare system in collaboration with Sciensano, the National Institute for Health and Disability Insurance (INAMI/RIZIV), and the FPS Public Health.

The strengths and weaknesses of the system are assessed using multiple indicators. The objective is to provide a complete, transparent, and accountable view of the Belgian health system's performance and enable monitoring of its evolution.

The current report provided a revised conceptual framework. The number of indicators increased from 120 to 145, which will be assessed during the next performance review with the publication of a report in 2024.

See more details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.